Orchestrated copper-loaded nanoreactor for simultaneous induction of cuproptosis and immunotherapeutic intervention in colorectal cancer
Open Access
- 9 November 2024
- journal article
- research article
- Published by Elsevier in Materials Today Bio
- Vol. 29, 101326
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Glutathione‐Scavenging Celastrol‐Cu Nanoparticles Induce Self‐Amplified Cuproptosis for Augmented Cancer ImmunotherapyAdvanced Materials, 2024
- A Bioactive Injectable Hydrogel Regulates Tumor Metastasis and Wound Healing for Melanoma via NIR‐Light Triggered HyperthermiaAdvanced Science, 2024
- A Self‐Amplifying ROS‐Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer ImmunotherapyAdvanced Science, 2024
- Stimulus‐Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer ImmunotherapyAdvanced Science, 2024
- Alendronate Triggered Dual‐Cascade Targeting Prodrug Nanoparticles for Enhanced Tumor Penetration and STING Activation of OsteosarcomaAdvanced Functional Materials, 2023
- Clinical Chemotherapeutic Agent Coordinated Copper‐Based Nanoadjuvants for Efficiently Sensitizing Cancer Chemo‐Immunotherapy by Cuproptosis‐Mediated Mitochondrial Metabolic ReprogrammingAdvanced Functional Materials, 2023
- Hollow Mesoporous Manganese Oxides: Application in Cancer Diagnosis and TherapySmall, 2022
- Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020Cancer Communications, 2021
- PD‐1/PD‐L1‐dependent immune response in colorectal cancerJournal of Cellular Physiology, 2020
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancersAdvanced Drug Delivery Reviews, 2020